Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Dymista (azelastine hydrochloride and fluticasone proprionate) Nasal Spray, 137 mcg/50mcg
Company: Meda Pharmaceuticals, Inc.
Application No.: 202236
Approval Date: 05/01/2012

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.


Date created: May 6, 2013
Updated: July 26, 2013

Back to Top    Drugs@FDA

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.